Please login to the form below

Not currently logged in
Email:
Password:

clinical benefit

This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.

FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm

FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm

In the post, they explained that although evidence from the Aduhelm programme was suggestive of clinical benefit, they came to the conclusion – alongside the FDA’s Peripheral and Central Nervous System ... Advisory Committee – that the trial data

Latest news

More from news
Approximately 1 fully matching, plus 179 partially matching documents found.

Latest Intelligence

  • Alzheimer’s disease: the search for a cure Alzheimer’s disease: the search for a cure

    Not all of the drugs entering clinical trials will go on to benefit patients, so we are increasing the probability of successfully delivering a disease- modifying treatment by targeting disease processes ... We now know that the diseases that cause

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    In response to the WHO study, a Gilead spokesperson said that there was “more robust evidence from multiple randomised, controlled studies published in peer-reviewed journals validating the clinical benefit of ... Lastly, the two randomised,

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    Baseline survival times are longer in early-stage disease, and other measures of clinical benefit become relevant such as avoidance of recurrence and quality of life. ... Which alternative endpoints can assess clinical benefit in early-stage disease?

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    The analysis of the expanded data set for one of the phase 3 trials, EMERGE, linked aducanumab to improvements on a clinical dementia scale. ... The preponderance of the data indicates aducanumab doesn’t provide a clinical benefit,’ Skorney wrote in

  • Novel endpoints in the digital age Novel endpoints in the digital age

    Every clinical trial has an endpoint, a measure used to determine if the drug in question provides therapeutic benefit. ... measure safety, efficacy and clinical benefit of a medicine in a trial.

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest appointments

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of

  • ICON's CEO named chair of ACRO ICON's CEO named chair of ACRO

    Trade body for clinical research organisation elects Ciaran Murray. The global trade body for clinical research organisations has elected ICON's CEO Ciaran Murray as chairman. ... I look forward to continuing the work that ACRO has done in promoting our

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...